Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
No validated dose-response relationship or proven clinical outcomes exist for subcutaneous NAD+ administration
Yadav, U., Kumar, P., Gupta, S
Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022
By supporting the production of red blood cells and oxygen delivery, it helps the body maintain consistent energy throughout the day
US$ 26.21
US$ 29.36
US$ 25.01
US$ 25.00
US$ 29.05
US$ 20.25
